Research article · 15 Apr 2026
Research articlePublished 2012
Transplant Education Practices and Attitudes in Dialysis Centers: Dialysis Leadership Weighs In
Abstract
When senior leadership endorses quality improvement priorities, their staff is more likely to comply. To honor Centers for Medicare and Medicaid Services’s (CMS) mandates, dialysis clinic managers must ensure that transplant education takes place within their centers. We surveyed 131 dialysis clinic managers in End Stage Renal Disease (ESRD) Network 12 (the Heartland Kidney Network) to understand their transplant attitudes, knowledge, active educational programs, and perceived barriers to transplant. Few reported that there was a designated transplant educator (40%) or formal transplant education program (33%) available at their dialysis centers. Transplant education most commonly occurring with all patients included educators (53%) or physicians (49%) discussing transplant with the patient, giving them handouts or brochures (40%), the transplant center phone numbers (36%), and referring them to other transplant educational resources (22%). Over half were dissatisfied with transplant education available (56%) and felt that their educators did not have sufficient time to educate (57%). Most did not know that a kidney transplant from a living donor is expected to last 15-20 years (78% incorrect) or that almost 90% of kidneys function for at least one year (71% incorrect). Managers with formal transplant education programs in their dialysis centers were more likely to report that their patients were talking to educators (80% vs. 49%, χ2=11.13, p<.01) and given handouts or brochures about transplant (67% vs. 33%, χ2=14.63, p<.01). Unless dialysis corporations implement specific transplant education policies and procedures, transplant centers support these initiatives, and CMS ensures compliance, transplant education within dialysis centers will be intermittent.
Subjects
Nephrology & UrologyMore from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Amy D. Waterman”
- BylineArticles whose byline prints “Christina Goalby”
- BylineArticles whose byline prints “Shelley S. Hyl”
- BylineArticles whose byline prints “Melanie McCabe”
- BylineArticles whose byline prints “Katrina M. Dinkel”
